Cases That Test Your Skills

Getting patients to talk about priapism

Author and Disclosure Information

Mr. Q, a college sophomore, stops taking his anxiolytic after experiencing a 4-hour erection. The problem: He’s too embarrassed to tell his psychiatrist about the episode, which could impair his sexual function.


 

References

CHIEF COMPLAINT: Anxiety and disordered sleep

Mr. Q, a college sophomore, reported symptoms of insomnia, anxiety, and sadness to the university health service. When in bed, he said, he would ruminate about whether he had studied adequately and would ultimately qualify for a graduate program. He exhibited no pervasive sadness, loss of interest or motivation, suicidal ideation, or loss of self-esteem. His medical history revealed no serious illness.

The student health psychiatrist diagnosed Mr. Q as having generalized anxiety disorder. She prescribed trazodone, up to 100 mg/d as needed, for the insomnia. For the next 3 weeks, he took one 25 mg dose each night. After that time, Mr. Q reported that the trazodone alleviated the insomnia and that he felt more rested and could study more effectively. He had stopped taking the medication.

Mr. Q, however, did not tell the health service psychiatrist that he had also experienced an uncomfortable erection that lasted about 4 hours and was not precipitated or accompanied by sexual activity. He finally experienced detumescence after several cold showers. He did not inform her of the episode because he felt embarrassed to discuss “such a thing” with a female physician.

After his anxiety and insomnia resurfaced, Mr. Q was referred to one of the authors.

Why did Mr. Q. develop priapism? How would you counsel him at this point?

Dr. Freed’s and Dr. Muskin’s observations

Priapism refers to a prolonged and painful erection that results from sustained blood flow into the corpora cavernosa. In contrast to a normal erection, both the corpus spongiosum and glans penis remain flaccid. Medical complications and reactions to drugs are well-documented causes.

Table 1

Drugs reported to cause priapism

Antidepressants
Trazodone and, in rare cases, phenelzine and sertraline; bupropion has been associated with clitoral priapism3
Antihypertensives that act via alpha blockade Labetalol, prazosin3-5
Metoclopramide when taken with thioridazine3,4
Sildenafil citrate6 (rare case reports)
Substances of abuse
Alcohol, marijuana, crack cocaine
Typical and atypical antipsychotics
Chlorpromazine, clozapine, fluphenazine, haloperidol, mesoridazine, molindone, levomepromazine, perphenazine, promazine, risperidone, thioridazine, thiothixene3-5

An erection in priapism may result from sexual stimulation/activity, although this is not typical. Sexually stimulated erections in priapism persist hours after the stimulation ceases.

High-flow priapism is rare, painless, and occurs when well-oxygenated blood stays in the corpora cavernosa. It may result from perineal trauma creating a fistula between an artery and the cavernosa. Because the blood is oxygenated, there is no tissue damage, intervention is not urgent, and the prognosis usually is good.

Low-flow priapism, the more prevalent type, is painful and occurs when venous blood remains in the corpora, resulting in hypoxia and ischemia. Approximately 50% of low-flow priapism cases can result in impotence.1

Because men often are embarrassed by priapism, they may not seek medical attention or mention a prior episode to their physicians. This neglect can be dangerous: Painful erections that persist for more than 4 hours can lead to impotence if left untreated.

The physician must surmount the patient’s reluctance to discuss the symptom. Inquiring about past priapism episodes as part of a complete patient history is essential. We suggest routinely asking patients taking priapism-causing psychotropics (Table 1) if they’ve had a recent erectile problem. Mentioning that a medication can cause uncomfortable and serious sexual side effects may prompt the patient to discuss such problems.

Above all, be direct. A straightforward inquiry about a sensitive medical condition usually draws an honest answer; the patient then realizes the subject is important and should not be embarrassed about it.

After the patient discloses a priapism episode, ask him:

  • Was the erection related to sexual activity or desire?
  • Were you using any other medications or illicit drugs when the erection occurred?
  • Do you have a systemic blood disorder?
  • Did you feel any pain during your erection? If so, how long did it persist?

Men who present during a priapism episode should immediately be sent to the ER for urologic treatment. Patients reporting a recent sustained erection should be referred to a urologist if they need to keep taking the priapism-causing drug. Urologic treatment is not necessary if the patient stops the medication and the priapism resolves.

Men who have had at least one past priapism episode and those taking alpha-adrenergic blockers should be instructed to visit the ER immediately if a painful, persistent erection develops. Patients also should be warned not to induce detumescence (such as by taking cold showers, drinking alcohol, or engaging in sexual activity) if the erection persists for more than 2 hours. Any delay in emergency care could lead to impotence.

HISTORY: A probable side effect

Pages

Recommended Reading

Getting to the bottom of problem drinking: The case for routine screening
MDedge Psychiatry
Treating schizophrenia in the ‘real world’
MDedge Psychiatry
Therapy-resistant major depression When to consider ECT: Algorithm seeks respect for neglected therapy
MDedge Psychiatry
ECT: Effective, but it has an image problem
MDedge Psychiatry
How to avoid ethnic bias when diagnosing schizophrenia
MDedge Psychiatry
Irritable bowel syndrome and psychiatric illness: Three clinical challenges
MDedge Psychiatry
Visual hallucinations and drug therapy
MDedge Psychiatry
Taking the ‘ouch’ out of IM antipsychotics
MDedge Psychiatry
Writing in the palm of your hand
MDedge Psychiatry
Therapy-resistant major depression The attraction of magnetism: How effective—and safe—is rTMS?
MDedge Psychiatry